Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 180.15 SEK 0.92% Market Closed
Market Cap: 49.1B SEK
Have any thoughts about
Getinge AB?
Write Note

Getinge AB
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Getinge AB
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Getinge AB
STO:GETI B
Cash Paid for Dividends
-kr1.2B
CAGR 3-Years
-39%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cash Paid for Dividends
-kr917m
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cash Paid for Dividends
-kr53.7m
CAGR 3-Years
-44%
CAGR 5-Years
-8%
CAGR 10-Years
-16%
Arjo AB (publ)
STO:ARJO B
Cash Paid for Dividends
-kr232m
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Sedana Medical AB (publ)
STO:SEDANA
Cash Paid for Dividends
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Getinge AB
Glance View

Market Cap
49.1B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
282.45 SEK
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Getinge AB's Cash Paid for Dividends?
Cash Paid for Dividends
-1.2B SEK

Based on the financial report for Dec 31, 2023, Getinge AB's Cash Paid for Dividends amounts to -1.2B SEK.

What is Getinge AB's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 5Y
-22%

Over the last year, the Cash Paid for Dividends growth was -6%. The average annual Cash Paid for Dividends growth rates for Getinge AB have been -39% over the past three years , -22% over the past five years .

Back to Top